Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. (ACRS) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Aclaris Therapeutics, Inc. (NASDAQ:ACRS).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerACRS Technical Analysis Summary
Aclaris Therapeutics, Inc. stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
This mix signals that Aclaris Therapeutics, Inc. is trading in a balanced range with no clear breakout yet.
RSI (14): 46.54
Stochastic %K: 19.23
Williams %R: -79.10
Rate of Change (ROC): -9.97
Takeaway:Aclaris Therapeutics, Inc. shows weakening momentum, with sellers gaining the edge.
MACD: -0.03
ADX: 17.04
ATR (14): 0.28
CCI (14): -71.03
Takeaway:Aclaris Therapeutics, Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Aclaris Therapeutics, Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:Aclaris Therapeutics, Inc. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:ACRS shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
Overall Recommendation:Aclaris Therapeutics, Inc. shows a Neutral outlook — indicators suggest balanced momentum with no clear directional trend.